40
Views
14
CrossRef citations to date
0
Altmetric
Original research

Paradigms for the identification of new genes in motor neuron degeneration

, , , , , , , & show all
Pages 249-257 | Received 09 Feb 2003, Accepted 07 Jul 2003, Published online: 10 Jul 2009

References

  • Deng HX, Hentati A, Tainer JA et al. Amyotrophic lateral sclerosis and structural defects in Cu/Zn superoxide dismutase. Science 1993; 261: 1047–1051.
  • Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyo- trophic lateral sclerosis. Nature 1993; 362: 59–62.
  • Hadano S, Hand CK, Osuga H et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis. Nat Genet 2001; 29: 166–173.
  • Yang Y, Hentati A, Deng HX et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001; 29: 160–165.
  • Puls I, Jonnakuty C, LaMonte BH et al. Mutant dynactin in motor neuron disease. Nat Genet 2003; 33: 455–456.
  • Blair IP, Bennett CL, Abel A et al. A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4) localizes to a 500-kb interval on chromosome 9q34. Neurogenetics 2000; 3: 1–6.
  • Chance PF, Rabin BA, Ryan SG et al. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet 1998; 62: 633–640.
  • Hentati A, Ouahchi K, Pericak-Vance MA et al. Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15–q22 markers. Neurogenetics 1998; 2: 55–60.
  • Hand CK, Khoris J, Salachas F et al. novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. Am J Hum Genet 2002; 70: 251–256.
  • Hosler BA, Siddique T, Sapp PC et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21–q22. JAMA 2000; 284: 1664–1669.
  • Lynch T, Sano M, Marder KS et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia- Parkinsonism-amyotrophy complex. 1994. Neurology 2001; 57: S39–S45.
  • Hafezparast M, Ahmad-Annuar A, Wood NW et al. Mouse models for neurological disease. Lancet Neurology 2002; 1: 215–224.
  • Waterston RH, Lindblad-Toh K, Birney E et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002; 420: 520–562.
  • Elsea SH, Lucas RE. The mousetrap: what we can learn when the mouse model does not mimic the human disease. ILAR J 2002; 43: 66–79.
  • Nicholson SJ, Witherden AS, Hafezparast M et al. Mice, the motor system, and human motor neuron pathology. Mamm Genome 2000; 11: 1041–1052.
  • Sweet HO. Muscle deficient (mdf). Mouse News Letter 2002; 68: 72.
  • Womack J. Muscle deficient symbol. Mouse News Letter 1978; 58: 50.
  • Jones JM, Albin RL, Feldman EL et al. mnd2: a new mouse model of inherited motor neuron disease. Genomics 1993; 16: 669–677.
  • Miyata Y. A new mutant mouse with motor neuron disease. Brain Res 1983; 312: 139–142.
  • Cox GA, Mahaffey CL, Frankel WN. Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Neuron 1998; 21: 1327– 1337.
  • Martin N, Jaubert J, Gounon P et al. A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat Genet 2002; 32: 443–447.
  • Hafezparast M, Klocke R, Ruhrberg C et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 2003; 300: 808–812.
  • Gurney ME, Pu H, Chiu AY et al. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science 1994; 264: 1772–1775.
  • Brown SD, Balling R. Systematic approaches to mouse mutagen- esis. Curr Opin Genet Dev 2001; 11: 268–273.
  • Chen Y, Yee D, Dains K et al. Genotype-based screen for ENU- induced mutations in mouse embryonic stem cells. Nat Genet 2000; 24: 314–317.
  • Chambers DM, Peters J, Abbott CM. The lethal mutation of the mouse wasted (wst) gene is a deletion that abolishes expression of a tissue-specific isoform of translation elongation factor 1alpha, encoded by the Eef1a2 gene. Proc Natl Acad Sci U S A 1998; 95: 4463–4468.
  • Meier J, Couillard-Despres S, Jacomy H et al. Extra neurofilament NF-L subunits rescue motor neuron disease caused by over- expression of the human NF-H gene in mice. J Neuropathol Exp Neurol 1999; 58: 1099–1110.
  • Rogers DC, Peters J, Martin JE et al. SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice. Neurosci Lett 2001; 306: 89–92.
  • Crawley JN. What’s wrong with my mouse? John Wiley & Sons Inc, New York. 2000.
  • Hatcher JP, Jones DN, Rogers DC et al. Development of SHIRPA to characterise the phenotype of gene-targeted mice. Behav Brain Res 2001; 125: 43–47.
  • Rogers DC, Jones DN, Nelson PR et al. Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res 1999; 105: 207–217.
  • Rogers DC, Fisher EM, Brown SD et al. Behavioural and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 1997; 8: 711–713.
  • Hrabe de Angelis MH, Flaswinkel H, Fuchs H et al. Genome- wide, large-scale production of mutant mice by ENU mutagen- esis. Nat Genet 2000; 25: 444–447.
  • Hatcher JP, Virley D, Hadingham SJ et al. The behavioural effect of middle cerebral artery occlusion on apolipoprotein-E deficient mice. Behav Brain Res 2002; 131: 139–149.
  • Lalonde R, Eyer J, Wunderle V, Strazielle C. Characterisation of NFH-LacZ transgenic mice with the SHIRPA primary screening battery and tests of motor coordination, exploratory activity, and spatial learning. Behav Processes 2003; 63: 9–19.
  • Houenou LJ, Blondet B, Li L et al. The paralyse mouse mutant: a new animal model of anterior horn motor neuron degeneration. J Neuropathol Exp Neurol 1996; 55: 698–703.
  • Falconer DS. Wobbler. Mouse News Letter 1956; 15: 23.
  • Nakamura M, Hayashi H, Kurata Y et al. morphological analysis of a new mutant mouse with paralytic club feet, peroneal muscular atrophy (pma). J Hirnforsch 1983; 24: 659–670.
  • Nonaka I, Kikuchi A, Suzuki T, Esaki K. Hereditary peroneal muscular atrophy in the mouse: an experimental model for congenital contractures (arthrogryposis). Exp Neurol 1986; 91: 571–579.
  • Woloschak GE, Rodriguez M, Krco CJ. Characterization of immunologic and neuropathologic abnormalities in wasted mice. J Immunol 1987; 138: 2493–2499.
  • Ranta S, Zhang Y, Ross B et al. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet 1999; 23: 233–236.
  • Letts VA, Felix R, Biddlecome GH et al. The mouse stargazer gene encodes a neuronal Ca2z-channel gamma subunit. Nat Genet 1998; 19: 340–347.
  • Marszalek JR, Williamson TL, Lee MK et al. Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport. J Cell Biol 1996; 135: 711–724.
  • Pernas-Alonso R, Perrone-Capano C, Volpicelli F, di Porzio U. Regionalized neurofilament accumulation and motoneuron degeneration are linked phenotypes in wobbler neuromuscular disease. Neurobiol Dis 2001; 8: 581–589.
  • Wong PC, Pardo CA, Borchelt DR et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105–1116.
  • Tu PH, Raju P, Robinson KA et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuro- nal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci U S A 1996; 93: 3155–3160.
  • Silver LM. Mouse genetics. Oxford: Oxford University Press, 1995.
  • Eubanks JH, Puranam RS, Kleckner NW et al. The gene encoding the glutamate receptor subunit GluR5 is located on human chromosome 21q21.1–22.1 in the vicinity of the gene for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 1993; 90: 178–182.
  • Witherden AS, Hafezparast M, Nicholson SJ et al. An integrated genetic, radiation hybrid, physical and transcription map of a region of distal mouse chromosome 12, including an imprinted locus and the ‘Legs at odd angles’ (Loa) mutation. Gene 2002; 283: 71–82.
  • Goldstein LS, Yang Z. Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu Rev Neurosci 2000; 23: 39–71.
  • Hafezparast M, Witherden A, Nicholson S et al. The kinesin light chain gene: its mapping and exclusion in mouse and human forms of inherited motor neuron degeneration. Neurosci Lett 1999; 273: 49–52.
  • Nolan PM, Peters J, Strivens M et al. A systematic, genome- wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet 2000; 25: 440–443.
  • Isaacs AM, Davies KE, Hunter AJ et al. Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Hum Mol Genet 2000; 9: 1865–1871.
  • Nelis E, Haites N, Van Broeckhoven C. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum Mutat 1999; 13: 11–28.
  • Ahmad-Annuar A, Shah P, Hafezparast M et al. No association with common Caucasian genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial motor neuron disorders. Amyotrophic lateral sclerosis and other diseases 2003; In press.
  • Balling R. ENU mutagenesis: analyzing gene function in mice. Annu Rev Genomics Hum Genet 2001; 2: 463–492.
  • LaMonte BH, Wallace KE, Holloway BA et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 2002; 34: 715–727.
  • Ripps ME, Huntley GW, Hof PR et al. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 1995; 92: 689–693.
  • Gibb BJ, Brion JP, Brownlees J et al. Neuropathological abnormalities in transgenic mice harbouring a phosphorylation mutant neurofilament transgene. J Neurochem 1998; 70: 492–500.
  • Lee MK, Marszalek JR, Cleveland DW. A mutant neurofilament subunit causes massive, selective motor neuron death: implica- tions for the pathogenesis of human motor neuron disease. Neuron 1994; 13: 975–988.
  • Oosthuyse B, Moons L, Storkebaum E et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28: 131–138.
  • Skene JP, Cleveland DW. Hypoxia and Lou Gehrig. Nat Genet 2001; 28: 107–108.
  • Al Chalabi A, Andersen PM, Nilsson P et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 1999; 8: 157–164.
  • Figlewicz DA, Krizus A, Martinoli MG et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 1757–1761.
  • Kunst CB, Messer L, Gordon J et al. Genetic mapping of a mouse modifier gene that can prevent ALS onset. Genomics 2000; 70: 181–189.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.